Clinical Trial Update: Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 imaging trial evaluating 68Ga-FAPI-46 PET/CT for imaging cancer-associated fibroblasts in localized pancreatic ductal adenocarcinoma; study currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• 68Ga-FAPI-46 PET/CT imaging agent (Gallium-68 labeled FAPI-46)

Snippet

Sponsor: Mayo Clinic | Conditions: Localized Pancreatic Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: RECRUITING